BIONi010-C TNNI3-mCherry/TNNI1-EGFP dual reporter cl. 74

General

Cell Line

hPSCreg name BIONi010-C-55
Cite as:
BIONi010-C-55 (RRID:CVCL_C9M9)
Alternative name(s)
BIONi010-C TNNI3-mCherry/TNNI1-EGFP dual reporter cl. 74
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
BIONi010-C-51
(BIONi010-C TNNI3-mCherry reporter)
BIONi010-C
(BIONi010-C, K3P53)
UCSFi001-A-26
(AICS-0037-172)
BIONi010-C-13
(BIONi010-C + NGN2 #I7-26)
BIONi010-C-2
(BIONi010-C ApoE E3/E3 #H8 P32)
BIONi010-C-18
(BIONi010-C TBK1 KO)
BIONi010-C-3
(BIONi010-C ApoE KO #KO30 P30)
BIONi010-C-19
(BIONi010-C IKBKE KO)
BIONi010-C-43
(BIONi010-C + aSNCA-wt AAVS1)
BIONi010-C-15
(BIONi010-C +dox inducible NGN2-GFP)
BIONi010-C-44
(BIONi010-C + aSNCA-A53T AAVS1)
BIONi010-C-64
(BIONi010-C-T2A-Nanoluciferase reporter cl. 29)
BIONi010-C-25
(BIONi010-C heterozygous TREM2 KO)
BIONi010-C-10
(HNF1AP291fsinsC +/- 54-5)
BIONi010-C-11
(HNF1AP291fsinsC -/- 66-1)
BIONi010-C-12
(HNF4ApR309C -/- 2-4)
BIONi010-C-6
(BIONi010-C ApoE E2/E2)
BIONi010-C-7
(BIONi010-C Trem2 R47H)
BIONi010-C-8
(BIONi010-C Trem2 T66M, #Y5-80)
BIONi010-C-9
(BIONi010-C CD33 KO)
BIONi010-C-49
(BIONi010-C + synapsin-m2rtTA + SNCA-wt)
BIONi010-C-17
(BIONi010-C TREM2 KO)
BIONi010-C-50
(BIONi010-C + synapsin-m2rtTA + SNCA-A53T)
BIONi010-C-56
(BIONi010-C-A713T-C25)
BIONi010-C-57
(BIONi010-C-A713T-C42)
BIONi010-C-52
(BIONi010-C with an APOE 2/2 genotype (with two functional alleles in contrast to BIONi010-C-6))
BIONi010-C-70
(BIONi010-C with an APOE 2/2 genotype with an additional, homozygous christchurch mutation)
BIONi010-C-53
(BIONi010-C with an APOE 3/3 genotype (with two functional alleles in contrast to BIONi010-C-2))
BIONi010-C-58
(BIONi010-C-A713T-C1)
BIONi010-C-71
(BIONi010-C with an APOE 3/3 genotype with an additional, homozygous christchurch mutation)
BIONi010-C-54
(BIONi010-C with an APOE 4/4 genotype (with two functional alleles in contrast to BIONi010-C-4))
BIONi010-C-59
(BIONi010-C-A713T-C33)
BIONi010-C-60
(BIONi010-C-R589C-C7)
BIONi010-C-61
(BIONi010-C-R589C-C16)
BIONi010-C-62
(BIONi010-C-R589C-C5)
BIONi010-C-63
(BIONi010-C-R589C-C9)
BIONi010-C-48
(BIONi010-C hMDR1)
BIONi010-C-24
(BIONi010-C Dox a-syn)
BIONi010-C-45
(BIONi010-C iCRE AAVS1 GBA1 LoxP EX5-6)
BIONi010-C-41
(BIONi010-C + iNGN2 Two-plasmid system/CRISPR-2)
BIONi010-C-65
(BiONI010-C-O16)
BIONi010-C-66
(BIONi010-C-N7)
BIONi010-C-4
(BIONi010-C ApoE E4/E4 #B44 P27)
BIONi010-C-42
(BIONi010-C + iCRE AAVS1)
BIONi010-C-5
(BIONi010-C CD33 E2del #N14 P26)
BIONi010-A
(K1P53)
BIONi010-B
(K2P53, BIONi010-B)
Last update 7th March 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Bioneer (BION)
Contact:
Bioneer (BION)
Owner Bioneer (BION)
Distributors
Derivation country Denmark

External Databases

BioSamples SAMEA8837436
Cellosaurus CVCL_C9M9
Wikidata Q123030806

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: not allowed
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity Black or African-American

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA3105780

Ethics

Also have a look at the ethics information for the parental line BIONi010-C .
Is there an MTA available for the cell line? Yes
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? GeneART (plasmids), Lonza (nucleofection), IDT (Crispr-Cas9 RNP)
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

The source cell information can be found in the parental cell line BIONi010-C.

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No
Methods used
RT-PCR

Vector free reprogramming

Other

Derived under xeno-free conditions
No
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzyme-free cell dissociation
EDTA
O2 Concentration 21 %
CO2 Concentration 5 %
Medium mTeSR™ Plus
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells

Microbiology / Virus Screening

Mycoplasma Negative

Certificate of Analysis

Is there a certificate of analysis available?
Yes
Passage: 17

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46 XY, normal male karyotype
Passage number: 18
Karyotyping method: G-Banding

Other Genotyping (Cell Line)

Genetic Modification

Genetic modifications not related to a disease
TNNI3 (target)
Gene knock-in
mCherry
IRES-mCherry was inserted in the 5'UTR of one of the alleles of TNNI3
CRISPR-associated (CRISPR/Cas) System
TNNI1 (target)
Gene knock-in
EGFP
IRES-EGFP was inserted in the 5'UTR of one of the alleles of TNNI1.
CRISPR-associated (CRISPR/Cas) System